{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:15:04Z","timestamp":1793931304373,"version":"4.8.0"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Lanzhou Science and Technology Program Project","award":["2023\u00e2\u20ac\u2018ZD\u00e2\u20ac\u2018185"],"award-info":[{"award-number":["2023\u00e2\u20ac\u2018ZD\u00e2\u20ac\u2018185"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,25]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Sarcopenia and sarcopenic obesity (SO) are geriatric syndromes characterized by reduced skeletal muscle mass and impaired muscle strength, whose specific biomarkers and underlying mechanisms remain unclear. This study aimed to conduct a meta-analysis and literature review on the associations between biomarkers and sarcopenia\/SO by collecting relevant publications over the past 15 years. We intended to further identify the shared and differential biomarkers of these disorders, thereby revealing their distinct pathophysiological processes and providing a basis for precise diagnosis and targeted intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A comprehensive literature search was performed in PubMed, Embase databases for all publications from December 2010 to December 2025. We included English articles describing the associations between serum biomarkers and sarcopenia\/SO, including cross-sectional studies, prospective cohort studies, and retrospective case studies, with no restrictions on race, population, or sample size. Literature screening was conducted in accordance with predefined inclusion and exclusion criteria. Relevant study data were extracted, and the quality of included studies was assessed. The mean difference and 95% confidence interval were used to calculate the pooled effect size.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 43 English articles investigating the associations between biomarkers and sarcopenia\/SO were finally included. Compared with non-sarcopenic patients, sarcopenic patients had elevated serum levels of C-reactive protein (CRP), interleukins, tumor necrosis factor, cystatin C, blood urea nitrogen, and high-density lipoprotein cholesterol (HDL-C). In contrast, higher serum levels of vitamin D, alanine transaminase, albumin, hemoglobin, TG, uric acid, blood glucose, and fasting insulin were associated with a lower incidence of sarcopenia. No significant differences were observed in WBC count, platelet count, aspartate transaminase, alkaline phosphatase, bilirubin, total cholesterol (TC), creatinine, erythrocyte sedimentation rate, low-density lipoprotein cholesterol (LDL-C), or thyroid-stimulating hormone levels between sarcopenic and non-sarcopenic patients. Compared with healthy individuals, SO patients had higher serum levels of CRP, LDL-C, TC, TG, WBC, creatinine, uric acid, fasting blood glucose, and fasting insulin, while higher levels of HDL-C and vitamin D were associated with a lower risk of SO. SO patients had lower TG levels than patients with simple obesity, with no significant differences in CRP, HDL-C, LDL-C, TC, vitamin D, blood glucose, or interleukin-6 levels between the 2 groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050799","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:00:35Z","timestamp":1790359235000},"page":"e50799","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Systematic review and meta-analysis of biomarkers of sarcopenia and sarcopenic obesity"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6627-6725","authenticated-orcid":false,"given":"Yaxian","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Endocrinology, the 940th Hospital Joint Logistics Support Forces of PLA, Lanzhou, Gansu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the 940th Hospital Joint Logistics Support Forces of PLA, Lanzhou, Gansu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyuan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the 940th Hospital Joint Logistics Support Forces of PLA, Lanzhou, Gansu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Xuan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the 940th Hospital Joint Logistics Support Forces of PLA, Lanzhou, Gansu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoai","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the 940th Hospital Joint Logistics Support Forces of PLA, Lanzhou, Gansu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261104","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/acel.12601","article-title":"Molecular and physiological manifestations and measurement of aging in humans.","volume":"16","author":"Khan","year":"2017","journal-title":"Aging Cell"},{"key":"R2-20261104","doi-asserted-by":"crossref","first-page":"116467","DOI":"10.1016\/j.bone.2022.116467","article-title":"Creatine supplementation for older adults: focus on sarcopenia, osteoporosis, frailty and cachexia.","volume":"162","author":"Candow","year":"2022","journal-title":"Bone"},{"key":"R3-20261104","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3904\/kjim.2016.193","article-title":"Sarcopenia and sarcopenic obesity.","volume":"31","author":"Choi","year":"2016","journal-title":"Korean J Intern Med"},{"key":"R4-20261104","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1016\/j.clnu.2021.06.009","article-title":"Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis.","volume":"40","author":"Gao","year":"2021","journal-title":"Clin Nutr"},{"key":"R5-20261104","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s13679-024-00571-2","article-title":"Sarcopenic obesity and cardiovascular disease: an overlooked but high-risk syndrome.","volume":"13","author":"Mirzai","year":"2024","journal-title":"Curr Obes Rep"},{"key":"R6-20261104","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.3390\/nu13113957","article-title":"Inflammation in relation to sarcopenia and sarcopenic obesity among older adults living with chronic comorbidities: results from the National Health and Nutrition Examination Survey 1999\u20132006.","volume":"13","author":"Karanth","year":"2021","journal-title":"Nutrients"},{"key":"R7-20261104","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"R8-20261104","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian Working Group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment.","volume":"21","author":"Chen","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"R9-20261104","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis.","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"R10-20261104","first-page":"1350","article-title":"How to estimate the sample mean and standard deviation from the sample size, median, extremes or quartiles?","volume":"17","author":"Luo","year":"2017","journal-title":"Chin J Evid Based Med"},{"key":"R11-20261104","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R12-20261104","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/metabo14060306","article-title":"Multidimensional assessment of sarcopenia and sarcopenic obesity in geriatric patients: creatinine\/cystatin C ratio performs better than sarcopenia index.","volume":"14","author":"Khalil","year":"2024","journal-title":"Metabolites"},{"key":"R13-20261104","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2147\/IJGM.S187285","article-title":"The impact of sarcopenic obesity on inflammation, lean body mass, and muscle strength in elderly women.","volume":"11","author":"Nascimento","year":"2018","journal-title":"Int J Gen Med"},{"key":"R14-20261104","doi-asserted-by":"crossref","first-page":"e0132908","DOI":"10.1371\/journal.pone.0132908","article-title":"Association of sarcopenic obesity with higher serum high-sensitivity C-reactive protein levels in Chinese older males - a community-based study (Taichung Community Health Study-Elderly, TCHS-E).","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"R15-20261104","doi-asserted-by":"crossref","first-page":"111409","DOI":"10.1016\/j.exger.2021.111409","article-title":"Associations between inflammatory markers and muscle strength in older adults according to the presence or absence of obesity.","volume":"151","author":"Ribeiro","year":"2021","journal-title":"Exp Gerontol"},{"key":"R16-20261104","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00223-019-00551-y","article-title":"Clinical manifestations and factors associated with osteosarcopenic obesity syndrome: a cross-sectional study in Koreans with obesity.","volume":"105","author":"Kim","year":"2019","journal-title":"Calcif Tissue Int"},{"key":"R17-20261104","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/cpf.12287","article-title":"Relationship between sarcopenic obesity\u2010related phenotypes and inflammatory markers in postmenopausal women.","volume":"37","author":"Dutra","year":"2015","journal-title":"Clin Physio Funct Imaging"},{"key":"R18-20261104","doi-asserted-by":"crossref","first-page":"1272854","DOI":"10.3389\/fcvm.2024.1272854","article-title":"Sarcopenia, sarcopenic obesity, and arterial stiffness among older adults.","volume":"11","author":"Fantin","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"R19-20261104","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.exger.2018.04.006","article-title":"Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: the concord health and ageing in men project.","volume":"108","author":"Scott","year":"2018","journal-title":"Exp Gerontol"},{"key":"R20-20261104","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.archger.2014.03.012","article-title":"Sarcopenia and sarcopenic obesity classifications and cardiometabolic risks in older women.","volume":"59","author":"dos Santos","year":"2014","journal-title":"Arch Gerontol Geriatr"},{"key":"R21-20261104","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.orcp.2012.02.003","article-title":"Sarcopenic obesity is closely associated with metabolic syndrome.","volume":"7","author":"Lu","year":"2013","journal-title":"Obes Res Clin Pract"},{"key":"R22-20261104","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12603-020-1332-5","article-title":"Sarcopenia, obesity and sarcopenia obesity in comparison: prevalence, metabolic profile, and key differences: results from WCHAT study.","volume":"24","author":"Liu","year":"2020","journal-title":"J Nutr Health Aging"},{"key":"R23-20261104","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3390\/antiox11040725","article-title":"Identification of coenzyme Q10 and skeletal muscle protein biomarkers as potential factors to assist in the diagnosis of sarcopenia.","volume":"11","author":"Yen","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"R24-20261104","doi-asserted-by":"crossref","first-page":"4026940","DOI":"10.1155\/2022\/4026940","article-title":"A combination of serum biomarkers in elderly patients with sarcopenia: a cross-sectional observational study.","volume":"2022","author":"Ying","year":"2022","journal-title":"Int J Endocrinol"},{"key":"R25-20261104","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.afos.2020.06.001","article-title":"Sarcopenia in women with hip fracture: a comparison of hormonal biomarkers and their relationship to skeletal muscle mass and function.","volume":"6","author":"Yee","year":"2020","journal-title":"Osteoporos Sarcopenia"},{"key":"R26-20261104","doi-asserted-by":"crossref","first-page":"788178","DOI":"10.3389\/fmed.2022.788178","article-title":"Plasma tumor necrosis factor-\u03b1 is associated with sarcopenia in elderly individuals residing in agricultural and pastoral areas of Xinjiang, China.","volume":"9","author":"Wumaer","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R27-20261104","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.3390\/diagnostics12102293","article-title":"Diagnostic value of inflammatory markers in elderly Arab women with sarcopenia.","volume":"12","author":"Aldisi","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R28-20261104","doi-asserted-by":"crossref","first-page":"1094388","DOI":"10.3389\/fcvm.2022.1094388","article-title":"Circulating miR-29b decrease in response to sarcopenia in patients with cardiovascular risk factors in older Chinese.","volume":"9","author":"He","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R29-20261104","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s41999-019-00197-x","article-title":"Serum creatinine and cystatin C-based index can be a screening biomarker for sarcopenia in older population.","volume":"10","author":"Singhal","year":"2019","journal-title":"Eur Geriatr Med"},{"key":"R30-20261104","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.2147\/IJGM.S457252","article-title":"Diagnostic value of nutritional risk index and other indices for predicting sarcopenia in the middle-aged and elderly population of China without cancer: a ROC curve analysis.","volume":"17","author":"Zou","year":"2024","journal-title":"Int J Gen Med"},{"key":"R31-20261104","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s40520-016-0626-2","article-title":"Serum markers of inflammation and oxidative stress in sarcopenia.","volume":"29","author":"Can","year":"2017","journal-title":"Aging Clin Exp Res"},{"key":"R32-20261104","doi-asserted-by":"crossref","first-page":"843610","DOI":"10.3389\/fendo.2022.843610","article-title":"High serum AST\/ALT ratio and low serum INS*PA product are risk factors and can diagnose sarcopenia in middle-aged and older adults.","volume":"13","author":"He","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R33-20261104","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/08952841.2019.1697161","article-title":"Advanced glycation end products are associated with sarcopenia in older women: aging marker dynamics.","volume":"33","author":"Eguchi","year":"2021","journal-title":"J Women Aging"},{"key":"R34-20261104","doi-asserted-by":"crossref","first-page":"20915","DOI":"10.18632\/aging.203498","article-title":"Reduced uremic metabolites are prominent feature of sarcopenia, distinct from antioxidative markers for frailty.","volume":"13","author":"Kameda","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"R35-20261104","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1186\/s12877-023-04485-x","article-title":"Plasma acylcarnitine in elderly Taiwanese: as biomarkers of possible sarcopenia and sarcopenia.","volume":"23","author":"Lo","year":"2023","journal-title":"BMC Geriatr"},{"key":"R36-20261104","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.maturitas.2017.08.009","article-title":"Potential early biomarkers of sarcopenia among independent older adults.","volume":"104","author":"Coto Montes","year":"2017","journal-title":"Maturitas"},{"key":"R37-20261104","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12877-021-02040-0","article-title":"Circulating MicroRNA-486 and MicroRNA-146a serve as potential biomarkers of sarcopenia in the older adults.","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Geriatr"},{"key":"R38-20261104","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1111\/ajag.13064","article-title":"A combined diagnostic approach based on serum biomarkers for sarcopenia in older patients with hip fracture.","volume":"41","author":"Yu","year":"2022","journal-title":"Australas J Ageing"},{"key":"R39-20261104","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.3390\/jcm9082554","article-title":"Phase angle as an indicator of sarcopenia, malnutrition, and cachexia in inpatients with cardiovascular diseases.","volume":"9","author":"Hirose","year":"2020","journal-title":"J Clin Med"},{"key":"R40-20261104","doi-asserted-by":"crossref","first-page":"e23946","DOI":"10.1002\/jcla.23946","article-title":"Comparative analysis of the association between various serum vitamin D biomarkers and sarcopenia.","volume":"35","author":"Yoo","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"R41-20261104","doi-asserted-by":"crossref","first-page":"111924","DOI":"10.1016\/j.exger.2022.111924","article-title":"Metabolomic profiles to explore biomarkers of severe sarcopenia in older men: a pilot study.","volume":"167","author":"Shin","year":"2022","journal-title":"Exp Gerontol"},{"key":"R42-20261104","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.3390\/diagnostics13132218","article-title":"Hemoglobin and endotoxin levels predict sarcopenia occurrence in patients with alcoholic cirrhosis.","volume":"13","author":"Shibamoto","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R43-20261104","first-page":"276","article-title":"Circulating miRNA-1-3p as biomarker of accelerated sarcopenia in patients diagnosed with chronic heart failure.","volume":"74","author":"Xu","year":"2022","journal-title":"Rev Invest Clin"},{"key":"R44-20261104","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3390\/cancers15092406","article-title":"Interleukin-6: a new marker of advanced-sarcopenic HCC cirrhotic patients.","volume":"15","author":"Dalbeni","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R45-20261104","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s12877-020-01857-5","article-title":"Inflammatory indexes are not associated with sarcopenia in Chinese community-dwelling older people: a cross-sectional study.","volume":"20","author":"Tang","year":"2020","journal-title":"BMC Geriatr"},{"key":"R46-20261104","doi-asserted-by":"crossref","first-page":"105115","DOI":"10.1016\/j.archger.2023.105115","article-title":"Development of multiple biomarker panels for prediction of sarcopenia in community-dwelling older adults.","volume":"115","author":"Shin","year":"2023","journal-title":"Arch Gerontol Geriatr"},{"key":"R47-20261104","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1186\/s12877-022-03491-9","article-title":"Determination of skeletal muscle mass by aspartate aminotransferase \/ alanine aminotransferase ratio, insulin and FSH in Chinese women with sarcopenia.","volume":"22","author":"Yin","year":"2022","journal-title":"BMC Geriatr"},{"key":"R48-20261104","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.clnesp.2023.06.002","article-title":"Serum creatinine-to-cystatin C ratio as an indicator of sarcopenia in hemodialysis patients.","volume":"56","author":"Yajima","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"R49-20261104","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12877-021-02146-5","article-title":"Cross-sectional associations among P3NP, HtrA, Hsp70, Apelin and sarcopenia in Taiwanese population.","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Geriatr"},{"key":"R50-20261104","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.exger.2018.06.013","article-title":"Is increased neutrophil lymphocyte ratio remarking the inflammation in sarcopenia?","volume":"110","author":"\u00d6zt\u00fcrk","year":"2018","journal-title":"Exp Gerontol"},{"key":"R51-20261104","doi-asserted-by":"crossref","first-page":"1162385","DOI":"10.3389\/fpubh.2023.1162385","article-title":"Diagnostics of inflammaging in relation to sarcopenia.","volume":"11","author":"Morawin","year":"2023","journal-title":"Front Public Health"},{"key":"R52-20261104","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/gerona\/glac151","article-title":"Serum retinol binding protein 4 as a potential biomarker for sarcopenia in older adults.","volume":"78","author":"Chang","year":"2023","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R53-20261104","doi-asserted-by":"crossref","first-page":"3000605211004226","DOI":"10.1177\/03000605211004226","article-title":"Relationship between serum bilirubin concentration and sarcopenia in patients with type 2 diabetes: a cross-sectional study.","volume":"49","author":"Wang","year":"2021","journal-title":"J Int Med Res"},{"key":"R54-20261104","doi-asserted-by":"crossref","first-page":"116959","DOI":"10.1016\/j.bone.2023.116959","article-title":"Circulating lumican as a potential biomarker for osteosarcopenia in older adults.","volume":"179","author":"Park","year":"2024","journal-title":"Bone"},{"key":"R55-20261104","doi-asserted-by":"crossref","first-page":"1185221","DOI":"10.3389\/fendo.2023.1185221","article-title":"Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management.","volume":"14","author":"Wei","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R56-20261104","doi-asserted-by":"crossref","first-page":"4493817","DOI":"10.1155\/2021\/4493817","article-title":"The critical role of oxidative stress in sarcopenic obesity.","volume":"2021","author":"Gonzalez","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"R57-20261104","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13098-023-01192-w","article-title":"Mitochondrial disorders as a mechanism for the development of obese Sarcopenia.","volume":"15","author":"Liao","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"R58-20261104","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3390\/nu17101711","article-title":"Impaired mitophagy contributes to pyroptosis in sarcopenic obesity zebrafish skeletal muscle.","volume":"17","author":"Tang","year":"2025","journal-title":"Nutrients"},{"key":"R59-20261104","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12877-023-04137-0","article-title":"Possible-sarcopenic screening with disturbed plasma amino acid profile in the elderly.","volume":"23","author":"Duan","year":"2023","journal-title":"BMC Geriatr"},{"key":"R60-20261104","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3389\/fphys.2017.01045","article-title":"The role of inflammation in age-related sarcopenia.","volume":"8","author":"Dalle","year":"2017","journal-title":"Front Physiol"},{"key":"R61-20261104","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/jcsm.12901","article-title":"Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review.","volume":"13","author":"Li","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R62-20261104","doi-asserted-by":"crossref","first-page":"1674892","DOI":"10.3389\/fphys.2025.1674892","article-title":"Pathophysiological mechanisms and emerging therapeutic strategies for muscle wasting: an integrative review.","volume":"16","author":"Huang","year":"2025","journal-title":"Front Physiol"},{"key":"R63-20261104","doi-asserted-by":"crossref","first-page":"13452","DOI":"10.3390\/ijms232113452","article-title":"Organokines, sarcopenia, and metabolic repercussions: the vicious cycle and the interplay with exercise.","volume":"23","author":"Minniti","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R64-20261104","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.3390\/ijms26115113","article-title":"Pathophysiological mechanisms underlying sarcopenia and sarcopenic obesity: a systematic review and meta-analysis of biomarker evidence.","volume":"26","author":"Feng","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R65-20261104","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.2147\/DMSO.S260382","article-title":"Sarcopenia coexisting with high adiposity exacerbates insulin resistance and dyslipidemia in Saudi adult men.","volume":"13","author":"Habib","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R66-20261104","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s42003-022-04246-3","article-title":"Vitamin D status modulates mitochondrial oxidative capacities in skeletal muscle: role in sarcopenia.","volume":"5","author":"Salles","year":"2022","journal-title":"Commun Biol"},{"key":"R67-20261104","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.3390\/nu15224832","article-title":"Interplay between vitamin D and adipose tissue: implications for adipogenesis and adipose tissue function.","volume":"15","author":"Lu","year":"2023","journal-title":"Nutrients"},{"key":"R68-20261104","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.3390\/ijms21155357","article-title":"Molecular mechanism contributing to malnutrition and sarcopenia in patients with liver cirrhosis.","volume":"21","author":"Meyer","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R69-20261104","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.3390\/ijms21113821","article-title":"Molecular aspects and treatment of iron deficiency in the elderly.","volume":"21","author":"Romano","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:01:30Z","timestamp":1793804490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":69,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050799","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"2026-07-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}